Mesalamine maintenance therapy for Crohn's disease.

Suppr

超能文献

作者信息

Feagan B G, McDonald J W

出版信息

Gastroenterology. 2001 Feb;120(2):585-6. doi: 10.1053/gast.2001.22159.

DOI:10.1053/gast.2001.22159

PMID:11271451

Abstract

摘要

相似文献

Mesalamine maintenance therapy for Crohn's disease.

Gastroenterology. 2001 Feb;120(2):585-6. doi: 10.1053/gast.2001.22159.

Mesalamine derivatives in the treatment of Crohn's disease.

Gastroenterol Clin North Am. 2004 Jun;33(2):303-17, ix-x. doi: 10.1016/j.gtc.2004.02.010.

Mesalazine as a maintenance treatment in Crohn's disease.

Gut. 1998 Jan;42(1):143-4. doi: 10.1136/gut.42.1.143b.

Mesalamine in the treatment of active Crohn's disease.

Gastroenterology. 2005 Jan;128(1):245-6; author reply 246. doi: 10.1053/j.gastro.2004.11.030.

Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.

Am J Gastroenterol. 2011 Oct;106(10):1857; author reply 1857-8. doi: 10.1038/ajg.2011.217.

Mesalamine and relapse prevention in Crohn's disease.

Gastroenterology. 2000 Aug;119(2):597. doi: 10.1053/gast.2000.16153.

Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.

Eur J Surg. 1998 Dec;164(12):903-9. doi: 10.1080/110241598750005066.

Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.

Inflamm Bowel Dis. 2005 Jun;11(6):616-7. doi: 10.1097/01.mib.0000160744.32396.02.

Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.

Curr Gastroenterol Rep. 1999 Oct;1(5):377-83. doi: 10.1007/s11894-999-0018-2.

5-aminosalicylates to prevent relapse of Crohn's disease after surgery.

Am J Gastroenterol. 2012 Mar;107(3):487; author reply 487-8. doi: 10.1038/ajg.2011.454.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Mesalamine maintenance therapy for Crohn's disease.

Gastroenterology. 2001 Feb;120(2):585-6. doi: 10.1053/gast.2001.22159.

Mesalamine derivatives in the treatment of Crohn's disease.

Gastroenterol Clin North Am. 2004 Jun;33(2):303-17, ix-x. doi: 10.1016/j.gtc.2004.02.010.

Mesalazine as a maintenance treatment in Crohn's disease.

Gut. 1998 Jan;42(1):143-4. doi: 10.1136/gut.42.1.143b.

Mesalamine in the treatment of active Crohn's disease.

Gastroenterology. 2005 Jan;128(1):245-6; author reply 246. doi: 10.1053/j.gastro.2004.11.030.

Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.

Am J Gastroenterol. 2011 Oct;106(10):1857; author reply 1857-8. doi: 10.1038/ajg.2011.217.

Mesalamine and relapse prevention in Crohn's disease.

Gastroenterology. 2000 Aug;119(2):597. doi: 10.1053/gast.2000.16153.

Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.

Eur J Surg. 1998 Dec;164(12):903-9. doi: 10.1080/110241598750005066.

Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.

Inflamm Bowel Dis. 2005 Jun;11(6):616-7. doi: 10.1097/01.mib.0000160744.32396.02.

Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.

Curr Gastroenterol Rep. 1999 Oct;1(5):377-83. doi: 10.1007/s11894-999-0018-2.

5-aminosalicylates to prevent relapse of Crohn's disease after surgery.

Am J Gastroenterol. 2012 Mar;107(3):487; author reply 487-8. doi: 10.1038/ajg.2011.454.